[
  {
    "date": "2023-12-30",
    "symbol": "NAMSW",
    "period": "FY",
    "netincomeloss": -176937000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "NewAmsterdam Pharma Company N.V.",
    "entitycentralindexkey": 1936258,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-41562",
    "entitytaxidentificationnumber": "00-0000000",
    "entityaddressaddressline1": "Gooimeer 2-35",
    "entityaddresscityortown": "Naarden",
    "entityaddresscountry": "NL",
    "entityaddresspostalzipcode": "1411 DC",
    "cityareacode": 31,
    "localphonenumber": "(0) 35 206 2971",
    "entityincorporationstatecountrycode": "P7",
    "security12btitle": "Ordinary shares, nominal value €0.12 per share",
    "tradingsymbol": "NAMS",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "true",
    "documentfinstmtrestatementrecoveryanalysisflag": "false",
    "auditorfirmid": 1243,
    "auditorname": "Deloitte Accountants B.V",
    "auditorlocation": "Eindhoven, The Netherlands",
    "cash": 340450000,
    "prepaidexpenseandotherassetscurrent": 6341000,
    "assetscurrent": 346791000,
    "propertyplantandequipmentnet": 46000,
    "operatingleaserightofuseasset": 55000,
    "intangibleassetsnetincludinggoodwill": 170000,
    "prepaidexpensenoncurrent": 35000,
    "assets": 347097000,
    "accountspayablecurrent": 16923000,
    "accountspayableandotheraccruedliabilitiescurrent": 11398000,
    "deferredrevenuecurrent": 8942000,
    "operatingleaseliabilitycurrent": 60000,
    "derivativeliabilitiescurrent": 12574000,
    "liabilitiescurrent": 49897000,
    "deferredrevenuenoncurrent": 1019000,
    "derivativeliabilitiesnoncurrent": 7788000,
    "liabilities": 58704000,
    "commonstockvalue": 10173000,
    "additionalpaidincapitalcommonstock": 590771000,
    "retainedearningsaccumulateddeficit": -316973000,
    "accumulatedothercomprehensiveincomelossnetoftax": 4422000,
    "stockholdersequity": 288393000,
    "liabilitiesandstockholdersequity": 347097000,
    "commonstockparorstatedvaluepershare": 0.12,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 82469768,
    "commonstocksharesoutstanding": 82469768,
    "revenuefromcontractwithcustomerexcludingassessedtax": 14090000,
    "researchanddevelopmentexpense": 159424000,
    "sellinggeneralandadministrativeexpense": 37633000,
    "operatingexpenses": 197057000,
    "operatingincomeloss": -182967000,
    "investmentincomeinterest": 11283000,
    "changeinfairvalueofearnoutandwarrants": 10284000,
    "foreigncurrencytransactiongainlossbeforetax": 5058000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -176910000,
    "incometaxexpensebenefit": 27000,
    "comprehensiveincomenetoftax": -176937000,
    "earningspersharebasic": -2.15,
    "earningspersharediluted": -2.15,
    "sharesoutstanding": 82469768,
    "stockissuedduringperiodvaluewarrantsexercised": 97000,
    "stockissuedduringperiodshareswarrantsexercised": 749741,
    "stockissuedduringperiodvaluestockoptionsexercised": 21000,
    "stockissuedduringperiodsharesstockoptionsexercised": 160247,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 24761000,
    "profitloss": -176937000,
    "depreciationdepletionandamortization": 49000,
    "noncashrentexpense": 6000,
    "changeinfairvalueofderivativeearnoutandwarrants": 10284000,
    "sharebasedcompensation": 24572000,
    "increasedecreaseinprepaymentsandotherreceivables": -4031000,
    "increasedecreaseinaccountspayable": 5070000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 5470000,
    "increasedecreaseindeferredrevenue": -8705000,
    "netcashprovidedbyusedinoperatingactivities": -141218000,
    "paymentstoacquireproductiveassets": 24000,
    "netcashprovidedbyusedininvestingactivities": -24000,
    "proceedsfromwarrantexercises": 8622000,
    "proceedsfromstockoptionsexercised": 290000,
    "netcashprovidedbyusedinfinancingactivities": 8912000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -132330000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 5052000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 340450000,
    "incometaxespaid": 27000,
    "lesseeoperatingleasetermofcontract": "P1Y",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "incometaxexaminationlikelihoodofunfavorablesettlement": "greater than 50% likelihood",
    "propertyplantandequipmentusefullife": "P5Y",
    "earnoutshares": 143002,
    "revenueperformanceobligationdescriptionofgoodorservice": "As such, two performance obligations for the Menarini License were identified at contract inception, comprising a license to use the Company’s intellectual property",
    "numberofperformanceobligations": 2,
    "contingentpayment": 863000000,
    "deferredrevenue": 9961000,
    "licenserevenueattributedfromlicenseperformanceobligations": 5385000,
    "licenserevenueattributedfromranddperformanceobligations": 8705000,
    "deferredrevenuerecognized": 8705000,
    "earnoutliabilityfairvaluedisclosure": 7788000,
    "financialliabilitiesfairvaluedisclosure": 12051000,
    "derivativeliabilitymeasurementinput": 11.17,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 7788000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -266000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofincomeextensiblelist": "http://www.newamsterdampharma.com/20231231#ChangeInFairValueOfEarnoutAndWarrants",
    "prepaidresearchanddevelopmentcostscurrent": 2337000,
    "otherprepaidexpensecurrent": 2123000,
    "valueaddedtaxreceivablecurrent": 1006000,
    "otherreceivablesnetcurrent": 875000,
    "accruedresearchanddevelopmentmaterialsandservicescurrent": 5945000,
    "accruedemployeebenefitscurrent": 3384000,
    "accruedprofessionalfeescurrent": 2069000,
    "commonstocknumberofvotepershare": 1,
    "commonstockvotingrights": "each holder of Ordinary Shares is entitled to one vote per share on all matters to be voted on by shareholders",
    "commonstockcapitalsharesreservedforfutureissuance": 16425868,
    "percentageofordinarysharesreservedforgrantwillincreaseannuallyofissuedandoutstandingshares": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 490067,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 255243,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 234824,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 12.19,
    "incrementalfairvaluefullyrecognized": 2900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 4.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P1Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsunrecognizedcompensationcost": 25200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsliabilityforunvestedordinaryshares": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 519999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 15783509,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2032129,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5230531,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.63,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.81,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 50796000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 37101000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.041,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.381,
    "allocatedsharebasedcompensationexpense": 14521000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 608779,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -107555000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -69355000,
    "currentfederaltaxexpensebenefit": 27000,
    "currentincometaxexpensebenefit": 27000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.258,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0294,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0071,
    "effectiveincometaxratereconciliationwarrants": -0.015,
    "effectiveincometaxratereconciliationtaxcredits": 0.0531,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.274,
    "effectiveincometaxratecontinuingoperations": -0.0002,
    "deferredtaxassetsamortizationanddepreciation": 21176000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 509000,
    "deferredtaxassetsoperatinglosscarryforwards": 75686000,
    "deferredtaxassetsleaseliabilityarrangements": 13000,
    "deferredtaxassetsinprocessresearchanddevelopment": 22884000,
    "deferredtaxassetstaxcreditfederal": 6904000,
    "deferredtaxassetstaxcreditmassachusetts": 2685000,
    "deferredtaxassetsgross": 129857000,
    "deferredtaxassetsvaluationallowance": 129845000,
    "deferredtaxassetsnet": 12000,
    "deferredtaxliabilitiesrightofuseasset": 12000,
    "operatinglosscarryforwards": 274600000,
    "taxcreditcarryforwardamount": 6900000,
    "sharesexchangingratio": 0.0213,
    "weightedaveragenumberofsharesoutstandingbasic": 82161956,
    "weightedaveragenumberofdilutedsharesoutstanding": 82161956,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 15783509,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 1,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.03,
    "definedcontributionplanemployermatchingadditionalcontributionuponemployeepercent": 0.02,
    "definedcontributionplancostrecognized": 120000,
    "estimatedmaximumcancellationfees": 15700000,
    "percentageofdevelopmentcostsincurred": 0.5
  }
]